Mission Statement, Vision, & Core Values (2026) of Poly Medicure Limited.

Founded in 1995 and headquartered in Delhi, Poly Medicure Limited (POLYMED.NS) has grown into a global medtech force with a portfolio of over 200 products spanning infusion therapy, anaesthesia, oncology, urology and gastroenterology, exporting to more than 125 countries and earning accolades such as the Medical Devices Company of the Year 2018 while being named India's Largest Exporter of medical devices for six consecutive years; operating 12 manufacturing facilities across three continents with a workforce of over 3,000 people, the company manufactures in excess of 1 billion devices annually, guided by a mission-"We create value for our stakeholders by providing patient-centric medical technology for a healthier world"-a vision to "Serve people through innovative healthcare solutions," and core values of Integrity, Ownership, Care, Learning and Inclusivity that steer product innovation, quality standards and global impact

Poly Medicure Limited (POLYMED.NS) - Intro

Established in 1995, Poly Medicure Limited (POLYMED.NS) is a leading Indian manufacturer and exporter of high-quality medical devices, dedicated to enhancing global healthcare through innovation, precision, and affordability. Headquartered in Delhi, India, the company operates state-of-the-art manufacturing facilities that adhere to international quality standards and certifications, serving hospitals, clinics, and distributors worldwide.

• Founded: 1995
• Headquarters: Delhi, India
• Manufacturing footprint: 12 facilities across three continents
• Workforce: Over 3,000 employees
• Product portfolio: More than 200 products
• Annual production: Over 1 billion medical devices
• Markets: Exports to more than 125 countries

Mission

To enhance global healthcare by delivering innovative, high-quality, affordable medical devices that improve patient outcomes and empower caregivers.

• Focus on patient safety and clinical efficacy
• Accessible pricing to expand reach in emerging and developed markets
• Continuous R&D and process optimization to drive quality and cost-efficiency

Vision

To be a globally trusted medical device leader, recognized for clinical excellence, sustainable manufacturing, and broad access to life-enhancing products.

• Global leadership in selected device categories
• Scalable manufacturing that meets international regulatory standards
• Long-term partnerships with healthcare systems and clinicians

Core Values

• Quality: Rigorous adherence to international standards across all facilities.
• Innovation: Sustained investment in product development and process improvements.
• Integrity: Ethical practices in manufacturing, supply chain, and customer engagement.
• Customer Focus: Clinician and patient-centric design and support.
• Affordability: Cost-conscious strategies to widen access without compromising quality.
• Sustainability: Responsible resource use and compliance with environmental and regulatory norms.

For a deeper look at Poly Medicure's history, ownership, mission and business model, see: Poly Medicure Limited: History, Ownership, Mission, How It Works & Makes Money

Poly Medicure Limited (POLYMED.NS) - Overview

• 'We create value for our stakeholders by providing patient-centric medical technology for a healthier world.' - a constant guiding promise that centers patient outcomes while balancing investor, employee and partner interests.
• Focus: patient-centric medical technology designed to improve clinical outcomes, safety and ease-of-use across acute care, critical care, cardiology, anaesthesia and dialysis.
• Stakeholder value: sustained product quality, regulatory compliance, supply reliability and margin-conscious growth to benefit shareholders and workforce alike.
• Global remit: product development and commercialisation aimed at improving health standards worldwide through exports, partnerships and direct market presence.

• To be a globally trusted medical device provider delivering high-quality, affordable and innovative solutions that transform patient care.
• Continued expansion into advanced therapy segments and higher-value consumables while scaling manufacturing and regulatory capabilities.

• Patient First - design and deliver with patient safety and clinical efficacy as primary metrics.
• Quality & Compliance - adhere to ISO, CE and US FDA/other regulatory standards across R&D and manufacturing.
• Innovation - invest in incremental and platform innovations that reduce costs, increase usability and open new clinical applications.
• Integrity & Accountability - transparent governance and ethical conduct in clinical, commercial and financial activities.
• Collaboration - partnerships with hospitals, distributors and research institutions to co-create solutions and expand reach.

• Manufacturing footprint: multiple facilities in India with capabilities across polymers, extrusion, injection moulding and final assembly.
• Global reach: products exported to 100+ countries spanning developed and emerging markets.
• Employee base: approximately 3,000+ employees across R&D, manufacturing, quality and commercial functions.
• Product portfolio: thousands of SKUs across critical care consumables, vascular access devices, cardiology consumables, anaesthesia and infusion sets.

• Annual R&D and regulatory investment runs as a percentage of revenue in the mid-single digits to support CE/FDA filings and product upgrades.
• Quality accreditations: multiple ISO certifications and CE-marked product lines; ongoing initiatives to expand US FDA-compliant product range.

• Portfolio premiumisation - migrate mix toward higher-margin, higher-complexity devices while retaining volume-critical consumables.
• Geographic diversification - deepen presence in North America and Europe while expanding penetration in LATAM, MENA and SEA markets.
• Manufacturing scale and backward integration - increase in-house polymer-processing and component capabilities to secure margins and supply-chain resilience.
• Digital and clinical evidence - strengthen post-market surveillance, clinical data generation and digital connectivity in device ecosystems.

Poly Medicure Limited (POLYMED.NS) - Mission Statement

• Patient-centric manufacturing: designing products with safety, usability and cost-effectiveness in mind.
• Global reach: expanding access to critical disposables and devices across developed and emerging markets.
• Continuous innovation: sustained R&D, process optimization and regulatory compliance to bring new solutions to market.
• Sustainable operations: scaling production while reducing waste and improving supply-chain resilience.

• 'Serve people' - reflected in high export share and product portfolio targeting critical care, anaesthesia, vascular access and infusion therapy.
• 'Innovative healthcare solutions' - evidenced by steady R&D spending, new device launches, regulatory clearances and IP filings.
• Strategic initiatives - capacity expansions, quality certifications and partnerships to respond to global health demands and supply-chain shifts.

• Grow high-margin product mix (e.g., advanced vascular and safety devices).
• Increase backward integration to control costs and quality.
• Expand regulated-market approvals (FDA/CE) to boost sales in North America and Europe.
• Maintain export-led growth while strengthening domestic hospital and institutional channels.

Poly Medicure Limited (POLYMED.NS) - Vision Statement

Poly Medicure Limited envisions becoming a global leader in lifesaving medical devices by delivering safe, affordable, and high‑quality healthcare solutions while embedding strong ethical governance and stakeholder value creation across all operations.

Mission Statement

To design, manufacture and deliver innovative medical devices that improve patient outcomes worldwide, driven by integrity, ownership, care, learning and inclusivity.

Core Values

• Integrity - Transparency, accountability and ethical practices across manufacturing, supply chain and commercial operations.
• Ownership - Empowering employees to take responsibility for quality, safety and outcomes at every stage.
• Care - Prioritizing patient safety, employee wellbeing and community health in product design and outreach.
• Learning - Continuous improvement through R&D investment, training and adoption of best practices and regulatory standards.
• Inclusivity - Fostering diverse teams and equitable access to healthcare solutions across markets.

How Values Translate into Action - Key Metrics & Operational Indicators

Governance & Ethical Framework

• Board oversight with independent directors and audit committees to ensure financial and compliance integrity.
• Robust quality management systems aligned with ISO and global regulatory norms to ensure patient safety.
• Whistleblower and grievance mechanisms reinforcing accountability and ownership at all levels.

People, Inclusion & Development

• Diversity policies aimed at gender balance and regional representation across functions.
• Structured learning paths, certification programs and cross‑functional rotations to embed continuous learning.
• Employee wellbeing initiatives, safety protocols and benefits aligning with the value of care.

Strategic Priorities Linked to Vision

• Expand product portfolio in critical care and minimally invasive devices through focused R&D.
• Scale exports and regulatory registrations to deepen presence in developed markets.
• Invest in automation and quality assurance to reinforce integrity and cost competitiveness.
• Strengthen community health programs and affordable access initiatives under CSR.

Further context and historical perspective on strategy, ownership and how Poly Medicure creates value can be explored here: Poly Medicure Limited: History, Ownership, Mission, How It Works & Makes Money